Approval for a product trade name change from arterx® surgical sealant to preveleak surgical sealant. The device, as modified, will be marketed under the trade name preveleak surgical sealant and is indicated for use in vascular reconstructions to achieve adjunctive hemostasis by mechanically sealing areas of leakage.
| Device | PREVELEAK SURGICAL SEALANT |
| Classification Name | Sealant, Polymerizing |
| Generic Name | Sealant, Polymerizing |
| Applicant | Baxter Healthcare Corporation |
| Date Received | 2014-05-22 |
| Decision Date | 2014-07-31 |
| PMA | P100030 |
| Supplement | S004 |
| Product Code | NBE |
| Advisory Committee | Cardiovascular |
| Supplement Type | Normal 180 Day Track No User Fee |
| Supplement Reason | Labeling Change - Indications/instructions/shelf Life/tradename |
| Expedited Review | No |
| Combination Product | No |
| Applicant Address | Baxter Healthcare Corporation one Baxter Parkway deerfield, IL 60015 |
Supplemental Filings
| Supplement Number | Date | Supplement Type |
|---|
| P100030 | | Original Filing |
| S016 |
2021-11-10 |
30-day Notice |
| S015 |
2021-06-28 |
30-day Notice |
| S014 |
2020-09-14 |
Real-time Process |
| S013 | | |
| S012 | | |
| S011 |
2017-07-31 |
30-day Notice |
| S010 |
2017-07-26 |
30-day Notice |
| S009 |
2017-07-07 |
135 Review Track For 30-day Notice |
| S008 |
2017-07-03 |
Panel Track |
| S007 |
2017-05-30 |
Real-time Process |
| S006 | | |
| S005 |
2016-07-26 |
Normal 180 Day Track No User Fee |
| S004 |
2014-05-22 |
Normal 180 Day Track No User Fee |
| S003 | | |
| S002 |
2013-09-03 |
Real-time Process |
| S001 |
2013-09-03 |
Real-time Process |
NIH GUDID Devices